XTX Topco’s Repare Therapeutics RPTX Stock Holding History

XTX Topco’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-116,933	Closed	-$304K	–	4301
2025 Q4	$304K	Buy	116,933 +69,386	+146%	+$140K	0.01%	2051
2025 Q3	$83.7K	Buy	47,547 +4,373	+10%	+$7K	﹤0.01%	2063
2025 Q2	$60K	Buy	+43,174	New	+$56.3K	﹤0.01%	1984
2024 Q4	–	Sell	-33,468	Closed	-$115K	–	2841
2024 Q3	$115K	Buy	33,468 +148	+0.4%	+$487	0.01%	1583
2024 Q2	$110K	Buy	+33,320	New	+$119K	0.01%	1398
2023 Q3	–	Sell	-22,021	Closed	-$233K	–	1948
2023 Q2	$233K	Sell	22,021 -26,793	-55%	-$276K	0.04%	902
2023 Q1	$480K	Buy	48,814 +23,845	+95%	+$274K	0.1%	316
2022 Q4	$367K	Buy	+24,969	New	+$374K	0.08%	451

XTX Topco's RPTX Position: Q1 2026 in Review

XTX Topco sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 116,933 shares — an estimated $304K sold.

XTX Topco first reported a position in RPTX in Q4 2022 and held it in 8 quarters. The position peaked at $480K in Q1 2023. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

XTX Topco reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
XTX Topco sold 116,933 Repare Therapeutics shares in Q1 2026, an estimated $304K.
XTX Topco first reported a position in Repare Therapeutics in Q4 2022 and held it in 8 quarters.
XTX Topco's Repare Therapeutics position peaked at $480K in Q1 2023.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.